Ipn Fr News Today

By Denny Jacob Merrimack Pharmaceuticals plans to hold a special shareholder meeting to approve a plan for a corporate dissolution. The biopharmaceutical...

By Adria Calatayud Ipsen shares fell after the French pharmaceutical company forecast lower profitability this year as it expects extra...

By Helena Smolak Ipsen's phase-three trial of prostate cancer drug Cabometyx yielded positive results, the company said late Monday. The French...

By David Sachs A drug to treat chronic liver disease developed by Ipsen and Genfit has gained a positive result in its phase-three trial, the companies said....

By Adria Calatayud Exelixis and Ipsen said a phase 3 clinical trial evaluating a combination of drugs cabozantinib and atezolizumab in metastatic...

By David Sachs Ipsen shares rose Thursday after the French pharmaceutical firm raised its 2023 outlook. At 0749 GMT, Ipsen shares were up 4% to EUR114.50....

By Giulia Petroni The European Medicines Agency has recommended the approval of Ipsen's Bylvay treatment for cholestatic pruritus in patients with Alagille...

By Pierre Bertrand Ipsen said on Wednesday that the European Commission has decided against granting a marketing authorization for palovarotene for the...

European stocks were little changed on Tuesday, struggling to grab the baton despite positive global sentiment.

European stocks were cautiously higher on Tuesday, struggling to grab the baton despite positive global sentiment.